Skip to content

Upper Border of the Anal Transition Zone as a Landmark for Endoscopic Treatment of Internal Hemorrhoids: Feasibility and Clinical Value

Endoscopic Identification of the Anal Transition Zone and Its Clinical Application in the Treatment of Internal Hemorrhoids

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107924
Enrollment
Unknown
Registered
2025-08-21
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Internal Hemorrhoids

Interventions

Sclerotherapy group:Sclerotherapy guided by the reference demarcation line
Ligation group:Rubber band ligation guided by the reference demarcation line
Healthy group:None

Sponsors

Xi’an No.3 Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria for internal hemorrhoids group: 1.18-80 years old 2. Typical clinical manifestations of internal hemorrhoids with blood in the stool and prolapse; Inclusion criteria for the healthy group: 1.18-80 years old; 2. Patients who underwent routine gastroenteroscopy;

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Mixed hemorrhoids and external hemorrhoids; 2. Internal hemorrhoids with complications such as incarceration, thrombosis, ulceration, and infection; 3. Patients with severe cardiopulmonary, liver and kidney failure who cannot tolerate endoscopic surgery; 4. Accompanied by perianal infectious diseases, anal fistulas, active inflammatory bowel disease or colorectal organic diseases; 5. Severe coagulation dysfunction; 6. Allergy to sclerosing agents; 7. Patients with mental illness; 8. Those whose clinical data is incomplete or lost to follow-up.

Design outcomes

Primary

MeasureTime frame
Clinical symptom assessment;

Secondary

MeasureTime frame
Perianal and defecation scores;Patient-reported self-assessment of symptom impact on quality of life;Safety assessment;

Countries

China

Contacts

Public ContactYang Qi

Xi’an No.3 Hospital,

yangqidoctor@163.com+86 138 9197 8057

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026